These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta. Huchcroft S; Gunton P; Bowen T CMAJ; 1985 Nov; 133(9):871-5. PubMed ID: 2996738 [TBL] [Abstract][Full Text] [Related]
45. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)]. Spasova K; Vŭlcheva B Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168 [No Abstract] [Full Text] [Related]
46. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years. MacKenzie IZ; Findlay J; Thompson K; Roseman F BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770 [TBL] [Abstract][Full Text] [Related]
47. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Howard HL; Martlew VJ; McFadyen IR; Clarke CA Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694 [TBL] [Abstract][Full Text] [Related]
48. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant. Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601 [No Abstract] [Full Text] [Related]
49. A review of 58 Rh-isoimmunized cases. Rao RR; Gupte SC; Dastur NA; Walvekar VR; Pandit RD Asia Oceania J Obstet Gynaecol; 1986 Jun; 12(2):207-11. PubMed ID: 3021092 [No Abstract] [Full Text] [Related]
51. [Management of Rhesus isoimmunization. Viewpoint of the obstetrician]. Langer B Arch Pediatr; 1998 Nov; 5(11):1269-73. PubMed ID: 9853068 [TBL] [Abstract][Full Text] [Related]
52. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester]. Parant O J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834 [TBL] [Abstract][Full Text] [Related]
53. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen. Chaffe B; Ford J; Bills V Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141 [TBL] [Abstract][Full Text] [Related]
54. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians. Wee WW; Kanagalingam D Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158 [TBL] [Abstract][Full Text] [Related]
55. Antenatal Rh iso-immunization prophylaxis: implications for blood bank assessment. Larison J; Fadel H; Squires J; Barnwell C J Med Assoc Ga; 1985 Aug; 74(8):560-1. PubMed ID: 2995529 [No Abstract] [Full Text] [Related]
56. Reported management of threatened miscarriage by general practitioners in Wessex. Entwistle CC; Bowell PJ; Tovey LAD Br Med J (Clin Res Ed); 1987 Oct; 295(6604):998. PubMed ID: 2823956 [No Abstract] [Full Text] [Related]
57. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization]. Högman C; Nilsson BA Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372 [No Abstract] [Full Text] [Related]
59. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization]. College National de Gynecolegues et Obstetriciens Francais J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839 [No Abstract] [Full Text] [Related]